Search results for "Geste"

showing 10 items of 242 documents

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

2011

Abstract The purpose of this work was to determine whether there are differences in PIK3CA mutation status and PTEN protein expression between primary and matched metastatic breast tumors as this could influence patient management. Paraffin sections of 50 μm were used for DNA extraction and slides of 3 μm for immunohistochemistry (IHC) and FISH. Estrogen receptor, progesterone receptor, and HER2 IHC were repeated in a central laboratory for both primary tumors and metastases. PTEN levels were assessed by IHC and phosphoinositide 3-kinase (PI3K) pathway mutations were detected by a mass spectroscopy–based approach. Median age was 48 years (range: 30–83 years). Tumor subtype included 72% horm…

AdultCancer Researchmedicine.medical_specialtyClass I Phosphatidylinositol 3-KinasesReceptor ErbB-2Breast Neoplasmsmedicine.disease_causeArticleMetastasisMetastasisPhosphatidylinositol 3-KinasesBreast cancerInternal medicineBreast CancermedicinePTENHumansPTEN lossReceptorneoplasmsPI3K/AKT/mTOR pathwayAgedAged 80 and overMutationbiologyPTEN PhosphohydrolaseMiddle Agedmedicine.diseaseMetastatic breast cancerEndocrinologyOncologyReceptors EstrogenMutationbiology.proteinCancer researchImmunohistochemistryFemalePIK3CA mutationsReceptors ProgesteroneSignal TransductionMolecular cancer therapeutics
researchProduct

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

2005

CONTEXT: We undertook this study to estimate the prevalence of the various androgen excess disorders using the new criteria suggested for the diagnosis of polycystic ovary syndrome (PCOS). SETTING: The study was performed at two endocrine departments at the University of Palermo (Palermo, Italy). PATIENTS: The records of all patients referred between 1980 and 2004 for evaluation of clinical hyperandrogenism were reevaluated. All past diagnoses were reviewed using the actual diagnostic criteria. To be included in this study, the records of the patients had to present the following available data: clinical evaluation of hyperandrogenism, body weight and height, testosterone (T), free T, dehyd…

AdultHirsutismAdolescent17-alpha-HydroxyprogesteroneBody WeightOvaryAlopeciaBody HeightBody Mass IndexPelvisDiagnosis DifferentialPolycystic ovary syndrome HyperandrogenismNeoplasmsAcne VulgarisAndrogensHumansFemaleTestosteroneHyperandrogenismProgesteroneAnovulationPolycystic Ovary SyndromeRetrospective StudiesUltrasonography
researchProduct

Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency

1990

Intravenous corticotropin-releasing factor (CRF) and adrenocorticotropin hormone (ACTH) were administered in patients with adult onset 21-hydroxylase deficiency to compare their diagnostic capability as well as to investigate hypothalamic-pituitary-adrenal function in this disorder. Responses of 17-hydroxyprogesterone, which were markedly elevated compared with controls, were identical with CRF and ACTH. However, intravenous ACTH resulted in higher androstenedione levels in comparison to CRF. Adrenocorticotropin hormone also resulted in decreased cortisol responses, confirming a defect in steroidogenesis, a finding that was not evident with CRF. Plasma ACTH responses to CRF were similar in …

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentCorticotropin-Releasing HormoneLate onsetPeptide hormoneDecreased cortisolAdrenocorticotropic HormoneInternal medicineAdrenal GlandsHydroxyprogesteronesmedicineHumansTestosteroneIn patientAndrostenedioneAdrenal Hyperplasia Congenitalbiologybusiness.industry17-alpha-HydroxyprogesteroneAndrostenedione21-HydroxylaseObstetrics and GynecologyDiagnostic testEndocrinologyReproductive MedicinePituitary GlandSteroid Hydroxylasesbiology.proteinFemalebusinesshormones hormone substitutes and hormone antagonistsHormoneFertility and Sterility
researchProduct

Physiological Estrogen Replacement May Enhance the Effectiveness of the Gonadotropin-Releasing Hormone Agonist in the Treatment of Hirsutism

1994

GnRH agonists (GnRH-A) have been used for the treatment of hirsutism in women with ovarian hyperandrogenism. However, significant side-effects, including vasomotor symptoms and bone loss, have prevented the long term use of this therapy. In this study, we evaluated the effects of low dose (physiological) estrogen replacement on the side-effects and clinical and hormonal parameters of 22 hirsute women with ovarian hyperandrogenism when treated with a long-acting GnRH-A, Decapeptyl. Ten patients with Ferriman-Gallwey (FG) scores averaging 13.4 +/- 1.5 were randomly assigned to be treated with Decapeptyl alone (3.75 mg, im, every 28 days for 6 months), and 12 other patients with FG scores aver…

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismClinical BiochemistryOvaryMedroxyprogesterone AcetateGonadotropin-releasing hormoneBiochemistryGonadotropin-Releasing HormoneEndocrinologyGonadotropin-releasing hormone agonistInternal medicinemedicineHumansMedroxyprogesterone acetateEstrogen replacementConjugated Equine EstrogensTestosteronehirsutismTriptorelin PamoateVasomotorbusiness.industryEstrogen Replacement TherapyBiochemistry (medical)HyperandrogenismObstetrics and GynecologyDrug SynergismGeneral Medicinemedicine.diseaseMenstruationmedicine.anatomical_structureEndocrinologyEstrogenGonadotropins PituitaryAndrogensDrug Therapy CombinationFemalebusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugObstetrical & Gynecological Survey
researchProduct

The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency)

1984

We describe 5 adult women with severe hirsutism due to late onset 21-hydroxylase deficiency. Diagnosis was performed on the finding of high serum 17-hydroxyprogesterone (17OHP) levels with a marked hyperresponse to an ACTH test. The endocrine study showed in most patients a gonadotropin behavior similar to that observed in classical polycystic ovary (PCO) syndrome. Prolactin levels were slightly increased in basal conditions and presented an exaggerated response to TRH stimulation.

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismLate onsetEndocrinologyAdrenocorticotropic HormoneInternal medicineHydroxyprogesteronesmedicineHumansEndocrine systemGonadal Steroid HormoneshirsutismAdrenal Hyperplasia Congenitalbiologybusiness.industry17-alpha-HydroxyprogesteroneVirilization21-HydroxylaseLuteinizing Hormonemedicine.diseasePolycystic ovaryProlactinProlactinEndocrinologySteroid Hydroxylasesbiology.proteinFemaleSteroid 21-HydroxylaseFollicle Stimulating Hormonemedicine.symptomGonadotropinbusinesshormones hormone substitutes and hormone antagonistsJournal of Endocrinological Investigation
researchProduct

High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms

2010

Objective To verify the conclusions of the Endocrine Society Guidelines that patients with mild hirsutism and no other important clinical signs (menstrual irregularities, infertility, central obesity, acanthosis nigricans, rapid progression of the hirsutism, clitoromegaly) should not be further studied. Design Retrospective study in patients referred because of mild hirsutism and no other clinical signs. Setting Department of Clinical Medicine of the University of Palermo. Patient(s) One hundred fifty-two patients with mild hirsutism. Intervention(s) Measurement of serum testosterone, dehydroepiandrosterone sulfate, 17-OH-Progesterone, assessment of ovulation by measurement of progesterone …

AdultInfertilityHirsutismmedicine.medical_specialtyPediatricsSettore MED/09 - Medicina Internaendocrine system diseasesmedia_common.quotation_subjectClitoromegalyYoung Adultchemistry.chemical_compoundDehydroepiandrosterone sulfatePrevalenceHumansMedicineOvulationAcanthosis nigricanshirsutismRetrospective Studiesmedia_commonGynecologybusiness.industry17-alpha-HydroxyprogesteroneHyperandrogenismObstetrics and Gynecologymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsReproductive Medicinechemistrypolycystic ovary syndromeFemalemedicine.symptombusiness
researchProduct

High progesterone levels are associated with family history of premature coronary artery disease in young healthy adult men.

2019

Background & aimsThe offspring of patients with premature coronary artery disease (P-CAD) are at higher risk for cardiovascular disease, compared with subjects without a family history (FH) of P-CAD. The increased risk for cardiovascular disease in subjects with FH of early-onset CAD results from unfavorable genetic variants as well as social, behavioral and environmental factors, which are more prevalent in this group. Previous studies have shown that specific sex hormone levels may be associated with the risk of cardiovascular disease. The aim of this study was to compare wide range of biochemical marker levels including i.e. the levels of luteinizing hormone (LH), follicle-stimulating ho…

AdultMaleAdolescentOffspringSciencePhysiology030209 endocrinology & metabolismCoronary Artery Disease030204 cardiovascular system & hematologyBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineSex hormone-binding globulinRisk FactorsMedicineHumansYoung adultFamily historyTestosteroneProgesteroneMultidisciplinarybiologybusiness.industryQCholesterol HDLSmokingCase-control studyRCholesterol LDLCase-Control Studiesbiology.proteinMedicineFemaleLuteinizing hormonebusinessBody mass indexPloS one
researchProduct

Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases

2013

Background: Sexual hormones have an important role in many hormone-dependant tumors like breast and prostate carcinomas, and also a relationship has been found with bone metabolism and bone tumors. Some studies have demonstrated that the expression of hormonal receptors (HR) in osteosarcomas (OS) of long bones is associated with gender, histological grade, histological type, and possibly may be connection with pathogenesis and evolution. However, to our knowledge there are no studies of HR in osteosarcomas of craniofacial bones (OS-CF). Objectives: To assess the expression of hormonal receptors in OS-CF. Material and Methods: Twenty one cases of OS-CF were included in this study. Clinical o…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.drug_classEstrogen receptorOdontologíaYoung AdultProgesterone receptormedicineHumansCraniofacialReceptorGeneral DentistryAgedOsteosarcomaOral Medicine and Pathologybusiness.industryResearchMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseJaw NeoplasmsCiencias de la saludAndrogen receptorReceptors EstrogenOtorhinolaryngologyReceptors AndrogenEstrogenUNESCO::CIENCIAS MÉDICASOsteosarcomaFemaleSurgeryReceptors ProgesteronebusinessProgressive disease
researchProduct

Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types.

2009

Cancer of the salivary gland is one of the common cancers in the head and the neck regions. This type of cancer develops in the minor and the major salivary glands, and it sometimes metastasizes to other organs, particularly the lung. Morphologic mimicry and similarity in the expression of steroid hormone receptors between salivary gland tumors and breast tumors are well-known phenomena and are occasionally debated in the field of surgical pathology. The expression of sex hormone receptors in some tumors suggests a role for these receptors in tumor pathogenesis and therapy. Previous studies of the expression of estrogens and progesterone receptors in salivary gland tumors have reported conf…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentAdenoma PleomorphicAdenocarcinomaPleomorphic adenomaNeoplasms Multiple PrimaryMajor Salivary GlandProgesterone receptormedicineHumansReceptorGeneral DentistryAgedAged 80 and overbusiness.industrySex hormone receptorMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Salivary Gland NeoplasmsImmunohistochemistrySteroid hormoneCarcinoma ex pleomorphic adenomaOtorhinolaryngologyReceptors EstrogenUNESCO::CIENCIAS MÉDICASAdenocarcinomaSurgeryFemalebusinessReceptors ProgesteroneMedicina oral, patologia oral y cirugia bucal
researchProduct

Responses of serum androgenic-anabolic and catabolic hormones to prolonged strength training.

1988

Endocrine and neuromuscular effects of prolonged strength training were investigated in 21 strength-trained male subjects during the course of a 24-week progressive strength training and during a subsequent detraining period of 12 weeks. Maximal isometric leg extensor force increased by 19% (P less than 0.001) during the first 20 weeks, followed by a plateau during the 4 latest weeks of training. During the course of the training period, no systematic change was found in serum testosterone concentrations, but there was a decreasing tendency in the concentrations of free testosterone (NS), 17-OH-progesterone (NS), androstenedione (P less than 0.05), dehydroepiandrosterone (P less than 0.05),…

AdultMalemedicine.medical_specialtyHydrocortisoneStrength trainingmedicine.drug_classDehydroepiandrosteronePhysical Therapy Sports Therapy and RehabilitationIsometric exercisePhysical strengthTranscortinInternal medicineHydroxyprogesteronesMedicineHumansOrthopedics and Sports MedicineTestosteroneTestosteroneHydrocortisoneTranscortinPhysical Education and Trainingbiologybusiness.industry17-alpha-HydroxyprogesteroneAndrostenedioneAndrogenEndocrinologybiology.proteinAndrogenssense organsbusinessmedicine.drugMuscle ContractionInternational journal of sports medicine
researchProduct